Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis

Pediatrics

Volumn 105, Issue 4 I, 2000, Pages 794-799

  Ellison, Julie A ^a,b   Patel, Leena ^a   Ray, David W ^a   David, Timothy J ^a   Clayton, Peter E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LEIGHTON HOSPITAL   (United Kingdom)

Author keywords

Adrenal suppression; Atopic dermatitis; Glucocorticoid resistance; Glucocorticoid sensitivity

Indexed keywords

BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; FLUDROXYCORTIDE; FLUOCINOLONE ACETONIDE; FLUOROMETHOLONE; FLUTICASONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; TETRACOSACTIDE;

ADOLESCENT; ADRENAL SUPPRESSION; ADULT; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; DRUG POTENCY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; MALE; PRIORITY JOURNAL;

EID: 0034007934     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.105.4.794     Document Type: Article

References (22)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereal. 1980;92:44-47
2. Ray DW. Molecular mechanisms of glucocorticoid resistance. J Endocrinol. 1996;149:1-5
3. Barnes PJ, Adcock IM. Steroid resistance in asthma. Q J Med. 1995;88: 455-468
4. Patel L, Clayton PE. Clinical usefulness of the low dose ACTH test. J Endocrinol Invest. 1999;22:401-404
5. Patel L, Clayton PE, Addison GM, Price DA, David TJ. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol. 1995;132:950-955
6. Dickstein G, Shechner C, Nicholson W, Rosner I, Shen-Orr Z, Lahav M. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991;72:773-778
7. Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (ltg) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab. 1995;80:1301-1305
8. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CGD. The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol. 1991;130:475-479
9. Crowley S, Hindmarsh PC, Honour JW, Brook CGD. Reproducibility of the cortisol response to stimulation with a low dose of ACTH (1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol. 1993;136:167-172
10. Stewart PM, Corrie J, Seckl JR, et al. A rational approach for assessing the hypothalamic-pituitary-adrenal-axis. Lancet. 1988;1:1208-1210
11. Crosby SR, Stewart MF, Ratcliffe JG, White A. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay. J Clin Endocrinol Metab. 1988;67:1272-1277
12. DeVile CJ, Stanhope R. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol. 1997;47:37-41
13. White A, Smith H, Hoadley M, Dobson SH, Ratcliffe JG. Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotrophin in unextracted human blood using monoclonal antibodies. Clin Endocrinol. 1987;26:41-52
14. Ray DW, Gibson S, Crosby SR, Davies D, Davis JRE, White A. Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids. J Clin Endocrinol Metab. 1995;80:2430-2436
15. Fleischmajer R. The lack of systemic hydrocortisone effects after massive and prolonged external applications. J Invest Dermatol. 1964;36: 11-16
16. Carr RD, Belcher RW. Adrenocortical suppression with small doses of topical corticosteroids. Acta Derm Venereol. 1969;49:508-513
17. Feiwel M, James VHT, Barnett ES. Effect of potent topical steroids on plasma cortisol levels of infants and children with eczema. Lancet. 1969;1:485-487
18. Rasmussen JE. Percutaneous absorption of topically applied triamcinolone in children. Arch Dermatol. 1978;114:1165-1167
19. Weston WL, Sams JWM, Morris HG, Arthur JM, Blakeman GJ, Andresen M. Morning plasma cortisol levels in infants treated with topical fluorinated glucocorticosteroids. Pediatrics. 1980;65:103-106
20. Turpeinen M. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis. Eur J Pediatr. 1989;148: 729-317
21. Clayton MH, Leung DYM, Surs W, Szefler SJ. Altered glucocorticoid receptor binding in atopic dermatitis. J Allergy Clin Immunol. 1995;96: 421-423
22. Herd RM, Tidman MJ, Prescott RJ, et al. Prevalence of atopic eczema in the community: the Lothian atopic dermatitis study. Br J Dermatol. 1996;135:18-19